- Home
- SIF vs INAB Comparison
SIF vs INAB Comparison
Compare SIF & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- INAB
- Stock Information
- Founded
- SIF 1913
- INAB 2016
- Country
- SIF United States
- INAB United States
- Employees
- SIF N/A
- INAB N/A
- Industry
- SIF Office Equipment/Supplies/Services
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- INAB Health Care
- Exchange
- SIF Nasdaq
- INAB Nasdaq
- Market Cap
- SIF 17.5M
- INAB 18.8M
- IPO Year
- SIF N/A
- INAB 2021
- Fundamental
- Price
- SIF $2.80
- INAB $0.17
- Analyst Decision
- SIF
- INAB Strong Buy
- Analyst Count
- SIF 0
- INAB 2
- Target Price
- SIF N/A
- INAB $3.60
- AVG Volume (30 Days)
- SIF 4.2K
- INAB 1.1M
- Earning Date
- SIF 05-08-2025
- INAB 03-13-2025
- Dividend Yield
- SIF N/A
- INAB N/A
- EPS Growth
- SIF N/A
- INAB N/A
- EPS
- SIF N/A
- INAB N/A
- Revenue
- SIF $85,042,000.00
- INAB N/A
- Revenue This Year
- SIF N/A
- INAB N/A
- Revenue Next Year
- SIF N/A
- INAB N/A
- P/E Ratio
- SIF N/A
- INAB N/A
- Revenue Growth
- SIF 41.17
- INAB N/A
- 52 Week Low
- SIF $2.73
- INAB $0.16
- 52 Week High
- SIF $5.96
- INAB $1.74
- Technical
- Relative Strength Index (RSI)
- SIF 36.51
- INAB 27.23
- Support Level
- SIF $2.73
- INAB $0.16
- Resistance Level
- SIF $2.91
- INAB $0.25
- Average True Range (ATR)
- SIF 0.09
- INAB 0.02
- MACD
- SIF 0.02
- INAB -0.01
- Stochastic Oscillator
- SIF 26.92
- INAB 9.77
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.